[go: up one dir, main page]

US6248310B1 - Anti-tartar dental product and method - Google Patents

Anti-tartar dental product and method Download PDF

Info

Publication number
US6248310B1
US6248310B1 US09/538,564 US53856400A US6248310B1 US 6248310 B1 US6248310 B1 US 6248310B1 US 53856400 A US53856400 A US 53856400A US 6248310 B1 US6248310 B1 US 6248310B1
Authority
US
United States
Prior art keywords
composition
phosphate
calcium
sodium
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/538,564
Inventor
G Jae Lee
Alexander George Ziemkiewicz
David Robert Williams
Stephen Roy Barrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chesebrough Ponds USA Inc
Original Assignee
Chesebrough Ponds USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chesebrough Ponds USA Inc filed Critical Chesebrough Ponds USA Inc
Priority to US09/538,564 priority Critical patent/US6248310B1/en
Application granted granted Critical
Publication of US6248310B1 publication Critical patent/US6248310B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits

Definitions

  • the invention relates to new anti-tartar systems, dentifrice compositions containing these systems and their use in controlling tartar accumulation on teeth.
  • Tartar known also as calculus
  • calculus is a hard mineralized deposit which forms around teeth. This formation arises from deposition of crystals of calcium phosphate in the pellicle and the extracellular matrix of dental plaque.
  • Various forms of calcium phosphate have been identified but the most difficult to remove and thermodynamically most stable form is called hydroxyapatite (HAP).
  • HAP hydroxyapatite
  • Amorphous forms of calcium phosphate are believed to be the precursors of HAP.
  • Regular brushing can usually remove the amorphous forms but is not fully effective to dislodge the final stable calculus form. Therefore it is desirable to prevent amorphous forms of calcium phosphate from transforming into HAP.
  • the art has recognized that agents which interfere with the formation of HAP crystallization will be effective anti-tartar agents.
  • Soluble inorganic pyrophosphate salts have over the last decade set the commercial standard as tartar control agents. This technology has been reported by Parran, Jr. et al. in a series of patents including U.S. Pat. No. 4,590,077, U.S. Pat. No. 4,515,772 and U.S. Pat. No. 4,684,518.
  • Anionic polymers especially carboxylate group functionalized polymers have been widely reported as effective against calculus.
  • Commercially most significant has been the use of synthetic, linear anionic polymers of higher molecular weight in combination with the inorganic pyrophosphates.
  • This technology derives from work done by Gaffar et al. reported in a series of patents including U.S. Pat. No. 4,627,977, U.S. Pat. No. 4,806,340, U.S. Pat. No. 4,806,342, U.S. Pat. No. 4,808,400 and U.S. Pat. No. 4,808,401.
  • Anionic polymers described therein were found to inhibit the action of pyrophosphatase in the mouth and therefore allowing greater efficacy of the inorganic pyrophosphate.
  • the commercially operative polymer is a methyl vinyl ether/maleic anhydride copolymer, available under the GAF trademark Gantrez.
  • EP 0 341 662 (Amjad) cites a tartar inhibiting oral composition that includes a fluoride source, a dental abrasive, a carboxylate polymer and various phosphonic acids and their derivatives.
  • a phosphated acrylic acid/hydroxyethyl methacrylate/alkyl methacrylic acid ester copolymer has been suggested in GB 2 139 635B (Causton) as useful in an oral composition for treating teeth.
  • a still further object of the present invention is to provide a tartar control product of improved taste, safety and appearance.
  • An anti-tartar dental product comprising:
  • composition including:
  • a first composition comprising from about 0.01 to about 30% by weight of a water-soluble calcium phosphate or monolithic combination of water soluble calcium and phosphate salts, the composition having a pH less than 7;
  • a second composition including from about 0.01 to about 30% by weight of an alkaline material and an anti-caries effective amount of a fluoride ion source, the second composition having a pH greater than 7.5 and stored separately from the first composition in a manner to avoid contact between the phosphate and the alkaline material;
  • a method for controlling dental tartar which includes:
  • a first composition comprising from about 0.01 to about 30% by weight of a water-soluble calcium phosphate or monolithic combination of water soluble calcium and phosphate salts, the composition having a pH less than 7;
  • a second composition comprising from about 0.01 to about 30% by weight of an alkaline material and an anti-caries effective amount of a fluoride ion source, the second composition having a pH greater than 7.5 and stored separately from the first composition in a manner to avoid contact between the phosphate and the alkaline material;
  • compositions according to the present invention is not limited to unitary albeit multicompartmented dispensers nor to totally segregated compartments.
  • the dispenser may be a system in the form of two individual tubes quite separate from one another but packaged within a kit. Ribbons of the dentifrice from each tube are delivered to a toothbrush with mixing of the compositions occurring in the mouth. Delivery may also be from a single chambered tube except that each of the two compositions are semi solid strips positioned side-by-side touching but not mixing with one another. The relatively high viscosity of the products prevents any substantial transference of either pH change or components between the two strips. Illustrative of this technology is a U.S. product sold by Colgate® under the Baking Soda & Peroxide brand.
  • Still another method of delivery may be a single composition such as a paste or gel housing an alkaline environment.
  • Monocalcium phosphate compositions may be dispersed throughout the alkaline composition yet separated from contact by a coating encapsulating the phosphate. Activation occurs in the mouth through the presence of water or saliva which penetrates the encapsulating coating releasing phosphate salt to interact with the alkaline environment.
  • a critical component of the first composition of this invention is a water soluble calcium phosphate salt.
  • water soluble is meant a solubility of at least 0.1 gram in 100 ml water at 25° C. Most preferred is monocalcium hydrogen phosphate but also of potential use are calcium polyol phosphates (e.g. calcium glycerophosphate) and monocalcium ammonium phosphate salts.
  • Monolithic compositions of water soluble calcium and phosphate salts may be employed as alternatives to pre-formed water soluble calcium phosphates.
  • monolithic is meant separate water soluble calcium salts and phosphate salts which from solution may metathesize into calcium phosphates in solution or later upon mixing with the second composition.
  • Illustrative calcium salts include the halides, sulphates, nitrates, citrates, sugars and C 1 -C 6 carboxylates. Most preferred is calcium chloride, calcium sulphate and calcium acetate.
  • the monolithic partner phosphate salts may be alkali, ammonium or combination salts thereof. Examples include sodium ammonium phosphate, sodium phosphate, ammonium phosphate and potassium phosphate.
  • the water-soluble calcium phosphate salts or the monolithic calcium and phosphate salts (by weight of calcium and phosphate ions only) may be present in amounts ranging from 0.01 to 30%, preferably from 0.1 to 20%, optimally from 1 to 10% by weight of the first composition.
  • Solubility of the phosphate salt is maintained in the first composition by having an acidic environment.
  • the pH will be less than 7, preferably from 1 to 6.5, more preferably from 1.8 to 6, optimally from 2.5 to 5.5.
  • the second composition of the present invention requires an alkaline material so that the second composition has a pH greater than 7, preferably from 7.2 to 11, more preferably from 8 to 10, optimally from 8.5 to 9.5.
  • Alkaline materials suitable to achieve the pH are sodium bicarbonate, potassium bicarbonate, sodium carbonate, potassium carbonate, calcium carbonate, calcium oxide, sodium hydroxide, potassium hydroxide and mixtures thereof.
  • Amounts of the alkaline material may range from 0.1 to 60%, preferably from 0.5 to 30%, more preferably from 1 to 20%, optimally from 3 to 15% by weight of the second composition.
  • compositions of this invention may contain a fluoride anti-caries compound.
  • fluoride anti-caries compound examples include sodium fluoride, potassium fluoride, calcium fluoride, magnesium fluoride, stannous fluoride, stannous monofluorophosphate, sodium monofluorophosphate and copper fluoride. Most preferred is sodium fluoride. These sources should release anywhere from about 25 to about 5,000 ppm of fluoride ion.
  • the anti-caries compound will normally be present in an amount from about 0.01 to about 5%, preferably from 0.1 to 2.5%, optimally from 0.2 to 1.5% by weight of combined first and second compositions.
  • compositions of the present invention may be in the form of either a toothpaste, gel, powder or mouthwash. Most preferably the compositions are either pastes or gels. Especially suitable is where the phosphate salt is incorporated in a gel and the alkaline material incorporated into a paste. These compositions may include water or be anhydrous.
  • the phosphate salt as well as the alkaline material will be delivered through a pharmaceutically acceptable carrier.
  • pharmaceutically acceptable carrier will include such functional ingredients as water, humectants, abrasives, thickeners, surfactants and combinations thereof. Total levels of these materials may range anywhere from about 1 to about 99%, preferably from 20 to 80%, optimally from 30 to 60% by weight.
  • Acidity in the first composition may be achieved by formulating with a peroxide such as hydrogen peroxide, inorganic acids such as phosphoric, hydrochloric, nitric or boric acids, and organic C 2 -C 20 carboxylic acids such as citric, malic, lactic, alginic, succinic, tartaric and ascorbic acids.
  • Soluble salts may also be employed such as potassium bitartrate, sodium acid citrate, acid phosphate and pyrophosphate salts such as monosodium phosphate and disodium pyrophosphate.
  • Levels of the acidity inducing substances may range in amounts from about 0.1 to about 20%, preferably from about 0.5 to about 10%, optimally from 1.0 to 8% by weight of the first composition. Hydrogen peroxide and phosphoric acid are the preferred substances.
  • water when present may range in amounts from about 1 to 95%, preferably from 20 to 60%, optimally from 30 to 50% by weight of each of the compositions.
  • some formulations may be anhydrous.
  • Humectants are usually also present as one of the carriers. Illustrative of this category are sorbitol, maltitol, mannitol, glycerin and polyethylene glycols (e.g. Carbowax). Amounts of the humectant may range from 1 to 60%, preferably from about 5 to about 50%, optimally from 10 to 40% by weight of each composition.
  • Abrasives are normally present in toothpastes and some gels. These may include sodium metaphosphate, dicalcium phosphate (which is not considered a water-soluble phosphate), calcium pyrophosphate, silica, alumina, chalk, insoluble bicarbonate salts, and mixtures thereof. Amounts of the abrasives may range from about 1 to about 80%, preferably from 5 to 50% by weight of each composition.
  • Thickeners are a further type of carrier which can be included in the compositions of this invention.
  • Illustrative thickeners such as sodium carboxy-methyl cellulose, hydroxy ethyl cellulose, methyl cellulose, ethyl cellulose, gum tragacanth, gum arabic, gum karaya, sodium alginate, carrageenan, guar, xanthan gum, Irish moss, starch, modified starch, Carbomers (crosslinked acrylates) and mixtures thereof.
  • Inorganic substances may also be suitable, especially silica aerogels and magnesium aluminum silicate (e.g. Veegum).
  • Amounts of the thickener may range from about 0.01 to about 30%, preferably from 0.1 to 20%, optimally from 0.5 to 15% by weight of a composition.
  • Surfactants are also considered to be within the carrier definition.
  • Surfactants may either be anionic, nonionic, cationic or amphoteric. Most preferred are sodium lauryl sulphate, sodium dodecylbenzene sulphonate and sodium lauryl sarcosinate.
  • Surfactants may be present in an amount from about 0.5 to about 10%, preferably from 0.8 to 5% by weight of a composition.
  • Gel compositions are structured with substances than can be characterized as either humectants or surfactants.
  • a typical gel structurant is a polyoxyethylene-polyoxypropylene copolymer such as those sold by the BASF Corporation under the trademark Pluronic® F88, F99, F108 and F127. These materials are also known as Poloxamers and employed in amounts from about 5 to about 30%, preferably between about 18 and about 25% by weight of a composition.
  • Flavors may also be present in the compositions. These flavors may be based on oils of spearmint and peppermint. Examples of other flavoring materials include menthol, clove, wintergreen, eucalyptus and aniseed. Flavors may range in concentration from about 0.1 to about 5% by weight of a composition.
  • Sweetening agents may also be included such as saccharin, sodium cyclamate, aspartame, ace-sulfame, xylitol and combinations thereof at levels from 0.1 to 10% by weight of a composition.
  • Gel compositions incorporating hydrogen peroxide may include a sequestering agent(s) such as a pyrophosphate or other phosphate for chelation of ferric/ferrous ion as well as other transition metal ions to enhance hydrogen peroxide stability.
  • the sequestering agents may also be included within the paste compositions and are present in amounts from about 0.01 to about 20% by weight of a composition.
  • Most preferred chelatants are tetrasodium pyrophosphate, sodium tripolyphosphate and sodium hexametaphosphate, all known to be effective at lower pH with little affinity for calcium ion.
  • Other organic chelating agents such as sodium citrate and zinc citrate are also useful.
  • additives may also be incorporated such as preservatives, silicones, other synthetic or natural polymers such as Gantrez S97®, additional anti-tartar actives and antigingivitis actives.
  • additional anti-tartar agents are included zinc citrate, tetrasodium pyrophosphate, disodium pyrophosphate, dipotassium pyrophosphate, tetrapotassium pyrophosphate and mixtures thereof.
  • Antigingivitis actives may include thymol, Triclosan, stannous gluconate and mixtures thereof. Amounts of each of the aforementioned ingredients will depend upon their function. Generally each of these substances will range in amounts from about 0.01 to about 20% by weight of a composition.
  • Typical of the present invention is a first composition in the form of a gel and a second composition in the form of a paste.
  • Each of these formulations is held in a separate compartment of a dual-compartment dispenser similar to that disclosed in U.S. Pat. No. 5,038,963 (Pettengill et al.).
  • Another system typical of the present invention is a two part toothpaste. Each part is placed in a dual-compartment dispenser similar to that of Example 1.
  • PASTE 2A PASTE 2B COMPONENTS (% WEIGHT) (% WEIGHT) Sorbitol 70% Active 28.50 — Syloid 63XX (Hydrated Silica) 20.00 18.0 Glycerin 28.00 32.0 Monocalcium Phosphate 6.49 — Citric Acid 5.00 — Syloid 244 (Thickening Silica) 3.00 0.5 Xanthan Gum 0.50 — Sodium Fluoride — 0.44 FD&C Blue No. 1 0.01 — Sodium Bicarbonate — 25.0 Sodium Lauryl Sulphate — 1.5 Sodium Carboxymethyl Cellulose — 0.8 Flavor — 1.0 Titanium Dioxide — 0.4 Sodium Saccharin — 0.2 Water balance balance balance
  • Paste 2A The pH of Paste 2A is approximately 2.0.
  • Paste 2B has a pH of approximately 9.0. Strips of each of these are extruded onto a toothbrush. These strips are then brushed against the teeth thereby mixing them together.
  • Yet another system typical of the present invention is a two part toothpaste as described below. Each part is placed in a dual-compartment dispenser similar to that of Example 1.
  • PASTE 3A PASTE 3B COMPONENTS (% WEIGHT) (% WEIGHT) Sorbitol (70% Active) 30.50 — Alumina 20.00 18.0 Polyol II 10.00 32.0 Malic Acid 5.00 — Monocalcium Phosphate 4.50 — Syloid 244 (Thickening Silica) 3.00 0.5 Xanthan Gum 0.50 — Sodium Fluoride — 0.44 FD&C Blue No. 1 0.01 — Sodium Bicarbonate — 25.0 Sodium Lauryl Sulphate — 1.5 Sodium Carboxymethyl Cellulose — 0.8 Flavor — 1.0 Sodium Carbonate — 0.4 Sodium Saccharin — 0.2 Water balance balance balance balance
  • Paste 3A and 3B respectively are approximately 2 and 9. Strips of each of these pastes are placed onto a toothbrush. These strips are then brushed against the teeth thereby mixing them together.
  • This Example illustrates use of a monolithic calcium and phosphate salt combination to deliver the water soluble monocalcium phosphate component.
  • Separate gel and paste formulations representing the first and second compositions of this invention were prepared with the following compositions.
  • Yet another system typical of the present invention is a two part toothpaste as described below. Each part is placed in a dual compartment dispenser similar to that of Example 1.
  • This Example illustrates use of monocalcium phosphate in a Gel composition along with Triclosan solubilized in alcohol.
  • Triclosan is incorporated into a Paste composition of elevated pH for eventual combination with the Gel.
  • Example 1 A clinical trial was conducted to compare the dental product of Example 1 with an identical product that did not include monocalcium phosphate monohydrate.
  • the commercial toothpastes Aim® and Colgate Total® were used as reference samples, the latter product being a formulation containing triclosan.
  • Protocol for the clinical was as follows. Panelists were carefully selected to meet a long list of criteria such as exhibiting visible tartar within only 1 to 2 months of a professional cleaning. Tartar present on the lingual aspect of the 6 anterior Mandibular teeth was evaluated according to the Volpe/Manhold Scoring Index. Following an initial tartar assessment, each panelist received a thorough dental cleaning. Panelists were then given Aim® toothpaste for use over the following 3 weeks to allow tartar to build. Another tartar evaluation identified the baseline for a panelist's normal tartar growth rate. A second dental prophylaxis was then performed to remove dental tartar rendering the panelists ready to receive the first test product (Example 1 with monocalcium phosphate monohydrate). Tartar evaluations were then conducted after 2 and 3 weeks of product usage. Aim® was then given to the panelists for a 4 week washout period.
  • the Mandibular Anterior teeth were then scaled to remove tartar buildup over the washout period. Panelists were next assigned to use Colgate Total® for the subsequent 3 weeks. Evaluations were again conducted after the 2 and 3 week usage period. In a further phase of the test, the panelists were directed to use Aim® for another 4 week washout. Again, the Mandibular Anterior teeth were scaled to remove tartar buildup over the 4 week washout period. Panelists were then assigned to Example 1 where monocalcium phosphate monohydrate was absent (replaced by 2% zinc citrate) for the next 3 weeks. Tartar evaluations were conducted at the 2 and 3 week interval. Results of the tests are reported in the Table below.
  • Example 1 containing calcium phosphate had significantly better calculus inhibition performance than Aim®. The better performance is attributed to calcium phosphate which when absent from Example 1 allowed considerable more calculus formation.
  • Paste Composition 9A INGREDIENT WEIGHT % Polyol II (70% Sorbitol) 33.30 Syloid 63XX (Hydrated Silica) 30.00 Sodium Bicarbonate 10.00 Sylox 15X 2.00 Polyethylene Glycol 1450 (PEG 32) 5.00 Sodium Lauryl Sulphate 2.98 Alcohol 38B 2.84 Flavor 1.30 Cellulose Gum 0.80 Saccharin 0.54 Menthol 0.50 Sodium Fluoride 0.44 Titanium Dioxide 0.30 Water Balance
  • the gel compositions (containing monocalcium phosphate monohydrate) were different for each of the test cells.
  • the formulations are reported in the Tables below.
  • Table II provides the calculus reduction % results.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)

Abstract

An oral product and method is provided for inhibiting tartar formation on the teeth. The product is housed in a container and includes a first composition containing a water soluble calcium phosphate salt or monolithic combination of calcium and phosphate salts in a carrier with the first composition having a pH less than 7, and a second composition containing an alkaline material and a fluoride ion source in a carrier to achieve a pH greater than 7.5. The first and second compositions are separated from one another prior to use. When combined upon application to the teeth, the first and second compositions form a system for inhibiting tartar around the teeth.

Description

This is a Divisional application of Ser. No. 09/395,064 filed Sep. 13, 1999, which arises from U.S. Provisional Application Serial No. 60/129,779 filed Apr. 16, 1999.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to new anti-tartar systems, dentifrice compositions containing these systems and their use in controlling tartar accumulation on teeth.
2. The Related Art
Tartar, known also as calculus, is a hard mineralized deposit which forms around teeth. This formation arises from deposition of crystals of calcium phosphate in the pellicle and the extracellular matrix of dental plaque. Various forms of calcium phosphate have been identified but the most difficult to remove and thermodynamically most stable form is called hydroxyapatite (HAP). Amorphous forms of calcium phosphate are believed to be the precursors of HAP. Regular brushing can usually remove the amorphous forms but is not fully effective to dislodge the final stable calculus form. Therefore it is desirable to prevent amorphous forms of calcium phosphate from transforming into HAP. The art has recognized that agents which interfere with the formation of HAP crystallization will be effective anti-tartar agents.
Soluble inorganic pyrophosphate salts have over the last decade set the commercial standard as tartar control agents. This technology has been reported by Parran, Jr. et al. in a series of patents including U.S. Pat. No. 4,590,077, U.S. Pat. No. 4,515,772 and U.S. Pat. No. 4,684,518.
Anionic polymers, especially carboxylate group functionalized polymers have been widely reported as effective against calculus. Commercially most significant has been the use of synthetic, linear anionic polymers of higher molecular weight in combination with the inorganic pyrophosphates. This technology derives from work done by Gaffar et al. reported in a series of patents including U.S. Pat. No. 4,627,977, U.S. Pat. No. 4,806,340, U.S. Pat. No. 4,806,342, U.S. Pat. No. 4,808,400 and U.S. Pat. No. 4,808,401. Anionic polymers described therein were found to inhibit the action of pyrophosphatase in the mouth and therefore allowing greater efficacy of the inorganic pyrophosphate. The commercially operative polymer is a methyl vinyl ether/maleic anhydride copolymer, available under the GAF trademark Gantrez.
Organic phosphonic acid derivatives, some in polymeric form, have been disclosed in U.S. Pat. No. 3,934,002 (Haefele). EP 0 341 662 (Amjad) cites a tartar inhibiting oral composition that includes a fluoride source, a dental abrasive, a carboxylate polymer and various phosphonic acids and their derivatives. A phosphated acrylic acid/hydroxyethyl methacrylate/alkyl methacrylic acid ester copolymer has been suggested in GB 2 139 635B (Causton) as useful in an oral composition for treating teeth.
Evident from the foregoing review of the art is the considerable effort expended to devise better tartar control compositions. By no means, however, has any of the reported art been able to more than attenuate the problem. There is considerable room for improvement over the known control agents.
Accordingly, it is an object of the present invention to provide a product of improved efficacy in controlling formation of tartar.
A still further object of the present invention is to provide a tartar control product of improved taste, safety and appearance.
These and other objects of the present invention will become more apparent in light of the detailed description and Examples which follow.
SUMMARY OF THE INVENTION
An anti-tartar dental product is provided comprising:
(i) a container;
(ii) an oral composition stored within the container, the composition including:
(a) a first composition comprising from about 0.01 to about 30% by weight of a water-soluble calcium phosphate or monolithic combination of water soluble calcium and phosphate salts, the composition having a pH less than 7; and
(b) a second composition including from about 0.01 to about 30% by weight of an alkaline material and an anti-caries effective amount of a fluoride ion source, the second composition having a pH greater than 7.5 and stored separately from the first composition in a manner to avoid contact between the phosphate and the alkaline material;
(iii) instructions printed on the container directing use of the composition to control tartar when applied to the teeth.
A method is provided for controlling dental tartar which includes:
(i) obtaining a product which includes:
(a) a first composition comprising from about 0.01 to about 30% by weight of a water-soluble calcium phosphate or monolithic combination of water soluble calcium and phosphate salts, the composition having a pH less than 7; and
(b) a second composition comprising from about 0.01 to about 30% by weight of an alkaline material and an anti-caries effective amount of a fluoride ion source, the second composition having a pH greater than 7.5 and stored separately from the first composition in a manner to avoid contact between the phosphate and the alkaline material;
(ii) extruding a portion of first and second compositions onto a toothbrush; and
(iii) brushing the teeth with the combination of first and second compositions.
DETAILED DESCRIPTION OF THE INVENTION
Products intended for remineralization of teeth ordinarily employ calcium and phosphate ions. Naturally there is great concern that these ions can be diverted from remineralization to calculus forming hydroxyapatite. Now it has been discovered that when a water soluble calcium phosphate salt is stored within one composition held at a low pH and mixed after storage with a second composition having a high pH, the result is a significant reduction in normal tartar formation against the teeth.
Separate storage of the two compositions of this invention may be accomplished through a dual compartment dispenser. U.S. Pat. No. 4,687,663 (Schaeffer) discloses a dual-compartment package respectively storing a peroxide gel and a bicarbonate paste. Pump packaging with multiple compartments is reported in U.S. Pat. No. 5,038,963 (Pettengill et al.) and U.S. Pat. No. 5,020,694 (Pettengill) which are embodied in a U.S. product known as Mentadent® Baking Soda & Peroxide toothpaste.
Of course, delivery of compositions according to the present invention is not limited to unitary albeit multicompartmented dispensers nor to totally segregated compartments. The dispenser may be a system in the form of two individual tubes quite separate from one another but packaged within a kit. Ribbons of the dentifrice from each tube are delivered to a toothbrush with mixing of the compositions occurring in the mouth. Delivery may also be from a single chambered tube except that each of the two compositions are semi solid strips positioned side-by-side touching but not mixing with one another. The relatively high viscosity of the products prevents any substantial transference of either pH change or components between the two strips. Illustrative of this technology is a U.S. product sold by Colgate® under the Baking Soda & Peroxide brand. Still another method of delivery may be a single composition such as a paste or gel housing an alkaline environment. Monocalcium phosphate compositions may be dispersed throughout the alkaline composition yet separated from contact by a coating encapsulating the phosphate. Activation occurs in the mouth through the presence of water or saliva which penetrates the encapsulating coating releasing phosphate salt to interact with the alkaline environment.
A critical component of the first composition of this invention is a water soluble calcium phosphate salt. By the term “water soluble” is meant a solubility of at least 0.1 gram in 100 ml water at 25° C. Most preferred is monocalcium hydrogen phosphate but also of potential use are calcium polyol phosphates (e.g. calcium glycerophosphate) and monocalcium ammonium phosphate salts. Monolithic compositions of water soluble calcium and phosphate salts may be employed as alternatives to pre-formed water soluble calcium phosphates. By the term “monolithic” is meant separate water soluble calcium salts and phosphate salts which from solution may metathesize into calcium phosphates in solution or later upon mixing with the second composition. Illustrative calcium salts include the halides, sulphates, nitrates, citrates, sugars and C1-C6 carboxylates. Most preferred is calcium chloride, calcium sulphate and calcium acetate. The monolithic partner phosphate salts may be alkali, ammonium or combination salts thereof. Examples include sodium ammonium phosphate, sodium phosphate, ammonium phosphate and potassium phosphate. The water-soluble calcium phosphate salts or the monolithic calcium and phosphate salts (by weight of calcium and phosphate ions only) may be present in amounts ranging from 0.01 to 30%, preferably from 0.1 to 20%, optimally from 1 to 10% by weight of the first composition.
Solubility of the phosphate salt is maintained in the first composition by having an acidic environment. The pH will be less than 7, preferably from 1 to 6.5, more preferably from 1.8 to 6, optimally from 2.5 to 5.5.
The second composition of the present invention requires an alkaline material so that the second composition has a pH greater than 7, preferably from 7.2 to 11, more preferably from 8 to 10, optimally from 8.5 to 9.5. Alkaline materials suitable to achieve the pH are sodium bicarbonate, potassium bicarbonate, sodium carbonate, potassium carbonate, calcium carbonate, calcium oxide, sodium hydroxide, potassium hydroxide and mixtures thereof. Amounts of the alkaline material may range from 0.1 to 60%, preferably from 0.5 to 30%, more preferably from 1 to 20%, optimally from 3 to 15% by weight of the second composition.
Advantageously, compositions of this invention, especially the second composition may contain a fluoride anti-caries compound. Illustrative of such fluoride compounds are sodium fluoride, potassium fluoride, calcium fluoride, magnesium fluoride, stannous fluoride, stannous monofluorophosphate, sodium monofluorophosphate and copper fluoride. Most preferred is sodium fluoride. These sources should release anywhere from about 25 to about 5,000 ppm of fluoride ion. The anti-caries compound will normally be present in an amount from about 0.01 to about 5%, preferably from 0.1 to 2.5%, optimally from 0.2 to 1.5% by weight of combined first and second compositions.
The compositions of the present invention may be in the form of either a toothpaste, gel, powder or mouthwash. Most preferably the compositions are either pastes or gels. Especially suitable is where the phosphate salt is incorporated in a gel and the alkaline material incorporated into a paste. These compositions may include water or be anhydrous.
The phosphate salt as well as the alkaline material will be delivered through a pharmaceutically acceptable carrier. The term “pharmaceutically acceptable carrier” will include such functional ingredients as water, humectants, abrasives, thickeners, surfactants and combinations thereof. Total levels of these materials may range anywhere from about 1 to about 99%, preferably from 20 to 80%, optimally from 30 to 60% by weight.
Acidity in the first composition may be achieved by formulating with a peroxide such as hydrogen peroxide, inorganic acids such as phosphoric, hydrochloric, nitric or boric acids, and organic C2-C20 carboxylic acids such as citric, malic, lactic, alginic, succinic, tartaric and ascorbic acids. Soluble salts may also be employed such as potassium bitartrate, sodium acid citrate, acid phosphate and pyrophosphate salts such as monosodium phosphate and disodium pyrophosphate. Levels of the acidity inducing substances may range in amounts from about 0.1 to about 20%, preferably from about 0.5 to about 10%, optimally from 1.0 to 8% by weight of the first composition. Hydrogen peroxide and phosphoric acid are the preferred substances.
Among the carriers, water when present may range in amounts from about 1 to 95%, preferably from 20 to 60%, optimally from 30 to 50% by weight of each of the compositions. Of course some formulations may be anhydrous.
Humectants are usually also present as one of the carriers. Illustrative of this category are sorbitol, maltitol, mannitol, glycerin and polyethylene glycols (e.g. Carbowax). Amounts of the humectant may range from 1 to 60%, preferably from about 5 to about 50%, optimally from 10 to 40% by weight of each composition.
Abrasives are normally present in toothpastes and some gels. These may include sodium metaphosphate, dicalcium phosphate (which is not considered a water-soluble phosphate), calcium pyrophosphate, silica, alumina, chalk, insoluble bicarbonate salts, and mixtures thereof. Amounts of the abrasives may range from about 1 to about 80%, preferably from 5 to 50% by weight of each composition.
Thickeners are a further type of carrier which can be included in the compositions of this invention. Illustrative thickeners such as sodium carboxy-methyl cellulose, hydroxy ethyl cellulose, methyl cellulose, ethyl cellulose, gum tragacanth, gum arabic, gum karaya, sodium alginate, carrageenan, guar, xanthan gum, Irish moss, starch, modified starch, Carbomers (crosslinked acrylates) and mixtures thereof. Inorganic substances may also be suitable, especially silica aerogels and magnesium aluminum silicate (e.g. Veegum). Amounts of the thickener may range from about 0.01 to about 30%, preferably from 0.1 to 20%, optimally from 0.5 to 15% by weight of a composition.
Surfactants are also considered to be within the carrier definition. Surfactants may either be anionic, nonionic, cationic or amphoteric. Most preferred are sodium lauryl sulphate, sodium dodecylbenzene sulphonate and sodium lauryl sarcosinate. Surfactants may be present in an amount from about 0.5 to about 10%, preferably from 0.8 to 5% by weight of a composition.
Gel compositions are structured with substances than can be characterized as either humectants or surfactants. For instance, a typical gel structurant is a polyoxyethylene-polyoxypropylene copolymer such as those sold by the BASF Corporation under the trademark Pluronic® F88, F99, F108 and F127. These materials are also known as Poloxamers and employed in amounts from about 5 to about 30%, preferably between about 18 and about 25% by weight of a composition.
Flavors may also be present in the compositions. These flavors may be based on oils of spearmint and peppermint. Examples of other flavoring materials include menthol, clove, wintergreen, eucalyptus and aniseed. Flavors may range in concentration from about 0.1 to about 5% by weight of a composition.
Sweetening agents may also be included such as saccharin, sodium cyclamate, aspartame, ace-sulfame, xylitol and combinations thereof at levels from 0.1 to 10% by weight of a composition.
Gel compositions incorporating hydrogen peroxide may include a sequestering agent(s) such as a pyrophosphate or other phosphate for chelation of ferric/ferrous ion as well as other transition metal ions to enhance hydrogen peroxide stability. The sequestering agents may also be included within the paste compositions and are present in amounts from about 0.01 to about 20% by weight of a composition. Most preferred chelatants are tetrasodium pyrophosphate, sodium tripolyphosphate and sodium hexametaphosphate, all known to be effective at lower pH with little affinity for calcium ion. Other organic chelating agents such as sodium citrate and zinc citrate are also useful.
Other additives may also be incorporated such as preservatives, silicones, other synthetic or natural polymers such as Gantrez S97®, additional anti-tartar actives and antigingivitis actives. Among the additional anti-tartar agents are included zinc citrate, tetrasodium pyrophosphate, disodium pyrophosphate, dipotassium pyrophosphate, tetrapotassium pyrophosphate and mixtures thereof. Antigingivitis actives may include thymol, Triclosan, stannous gluconate and mixtures thereof. Amounts of each of the aforementioned ingredients will depend upon their function. Generally each of these substances will range in amounts from about 0.01 to about 20% by weight of a composition.
Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be understood as modified by the word “about”.
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight of either the first or second composition unless otherwise indicated.
EXAMPLE 1
Typical of the present invention is a first composition in the form of a gel and a second composition in the form of a paste. Each of these formulations is held in a separate compartment of a dual-compartment dispenser similar to that disclosed in U.S. Pat. No. 5,038,963 (Pettengill et al.).
INGREDIENT WEIGHT %
Gel Composition 1A
Glycerin 40.00
Pluronic F-127 20.00
Monocalcium Phosphate Monohydrate 1.60
Hydrogen Peroxide (35% Active) 4.285
Phosphoric Acid 0.40
FD&C Blue No. 1 0.01
Water Balance
Paste Composition 1B
Polyol II (70% Sorbitol) 47.00
Syloid 63XX (Hydrated Silica) 15.00
Sodium Bicarbonate 10.00
Sylox 15X 6.00
Polyethylene Glycol 1450 (PEG-32) 5.00
Ethyl Alcohol 38B 2.84
Sodium Lauryl Sulphate 2.98
Flavor 1.10
Cellulose Gum 0.80
Sodium Saccharin 0.54
Menthol 0.50
Sodium Fluoride 0.44
Titanium Dioxide 0.30
Water Balance
EXAMPLE 2
Another system typical of the present invention is a two part toothpaste. Each part is placed in a dual-compartment dispenser similar to that of Example 1.
PASTE 2A PASTE 2B
COMPONENTS (% WEIGHT) (% WEIGHT)
Sorbitol 70% Active 28.50  —
Syloid 63XX (Hydrated Silica) 20.00  18.0
Glycerin 28.00  32.0
Monocalcium Phosphate 6.49 —
Citric Acid 5.00 —
Syloid 244 (Thickening Silica) 3.00 0.5
Xanthan Gum 0.50 —
Sodium Fluoride — 0.44
FD&C Blue No. 1 0.01 —
Sodium Bicarbonate — 25.0
Sodium Lauryl Sulphate — 1.5
Sodium Carboxymethyl Cellulose — 0.8
Flavor — 1.0
Titanium Dioxide — 0.4
Sodium Saccharin — 0.2
Water balance balance
The pH of Paste 2A is approximately 2.0. Paste 2B has a pH of approximately 9.0. Strips of each of these are extruded onto a toothbrush. These strips are then brushed against the teeth thereby mixing them together.
EXAMPLE 3
Yet another system typical of the present invention is a two part toothpaste as described below. Each part is placed in a dual-compartment dispenser similar to that of Example 1.
PASTE 3A PASTE 3B
COMPONENTS (% WEIGHT) (% WEIGHT)
Sorbitol (70% Active) 30.50  —
Alumina 20.00  18.0
Polyol II 10.00  32.0
Malic Acid 5.00 —
Monocalcium Phosphate 4.50 —
Syloid 244 (Thickening Silica) 3.00 0.5
Xanthan Gum 0.50 —
Sodium Fluoride — 0.44
FD&C Blue No. 1 0.01 —
Sodium Bicarbonate — 25.0
Sodium Lauryl Sulphate — 1.5
Sodium Carboxymethyl Cellulose — 0.8
Flavor — 1.0
Sodium Carbonate — 0.4
Sodium Saccharin — 0.2
Water balance balance
The pH of Paste 3A and 3B respectively are approximately 2 and 9. Strips of each of these pastes are placed onto a toothbrush. These strips are then brushed against the teeth thereby mixing them together.
EXAMPLE 4
This Example illustrates use of a monolithic calcium and phosphate salt combination to deliver the water soluble monocalcium phosphate component. Separate gel and paste formulations representing the first and second compositions of this invention were prepared with the following compositions.
INGREDIENT WEIGHT %
Gel Composition 4A
Glycerin 40.00 
Pluronic F-127 ® 20.00 
Hydrogen Peroxide (35% Active) 4.29
Calcium Chloride Dihydrate 2.10
Dibasic Sodium Phosphate 1.00
Phosphoric Acid (85% Active) 1.50
Sodium Citrate 0.53
FD&C Blue No. 1 0.01
Water Balance
Paste Composition 4B
Polyol II (70% Sorbitol) 40.50 
Syloid 63XX (Hydrated Silica) 15.00 
Sodium Bicarbonate 10.00 
Sylox 15X 6.00
Polyethylene Glycol 1450 (PEG-32) 3.00
Ethyl Alcohol 38B 2.84
Sodium Lauryl Sulphate 2.98
Flavor 1.10
Cellulose Gum 0.80
Sodium Saccharin 0.54
Menthol 0.50
Sodium Fluoride 0.44
Titanium Dioxide 0.30
Water Balance
EXAMPLE 5
Yet another system typical of the present invention is a two part toothpaste as described below. Each part is placed in a dual compartment dispenser similar to that of Example 1.
INGREDIENT WEIGHT %
Gel Composition 5A
Glycerin 40.00 
Pluronic F-127 20.00 
Monocalcium Phosphate Monohydrate 3.10
Phosphoric Acid (85% Active) 0.85
Water Balance
Paste Composition 5B
Polyol II (70% Sorbitol) 46.68 
Syloid 63XX (Hydrated Silica) 15.00 
Sodium Carbonate 6.50
Sylox 15X (Hydrated Silica) 6.00
Polyethylene Glycol 1450 (PEG 32) 5.00
Ethyl Alcohol 38B 2.84
Sodium Lauryl Sulphate 2.98
Flavor 1.00
Cellulose Gum 0.80
Sodium Saccharin 0.50
Menthol 0.50
Sodium fluoride 0.44
Titanium Dioxide 0.30
Water Balance
The pH of 5A and 5B respectively are approximately 2.7 and 9.5
EXAMPLE 6
This Example illustrates use of monocalcium phosphate in a Gel composition along with Triclosan solubilized in alcohol.
INGREDIENT WEIGHT %
Gel Composition 6A
Glycerin 40.00 
Pluronic F-127 20.00 
Alcohol SDA 38B 5.00
Monocalcium Phosphate, Monohydrate 1.55
Phosphoric Acid (95% Active) 0.45
Hydrogen Peroxide (35% Active) 4.29
Irgacare ® MP (Triclosan) 0.67
Water Balance
Paste Composition 6B
Polyol II 70% Sorbitol 46.68 
Syloid 63XX (Hydrated Silica) 15.00 
Sodium Bicarbonate 10.00 
Sylox 15X (Hydrated Silica) 6.00
Polyethylene Glycol 1450 (PEG 32) 3.00
Ethyl Alcohol 38B 2.84
Sodium Lauryl Sulphate 2.98
Flavor 1.10
Cellulose Gum 0.80
Sodium Saccharin 0.54
Menthol 0.50
Sodium Fluoride 0.44
Titanium Dioxide 0.30
Water Balance
The pH of 6A and 6B respectively are approximately 2.7 and 9.2
EXAMPLE 7
Another Example is shown using monocalcium phosphate in a Gel composition. Here Triclosan is incorporated into a Paste composition of elevated pH for eventual combination with the Gel.
INGREDIENT WEIGHT %
Gel Composition 7A
Glycerin 40.00 
Pluronic F-127 20.00 
Hydrogen Peroxide (35% Active) 4.29
Monocalcium Phosphate, Monohydrate 3.10
Phosphoric Acid (95% Active) 0.85
Water Balance
Paste Composition 7B
Polyol II 44.93 
Syloid 63XX (Hydrated Silica) 30.00 
Sodium Carbonate 7.00
Sylox 15X (hydrated Silica) 2.00
Ethyl Alcohol 38B 2.84
Sodium Lauryl Sulphate 2.98
Flavor 1.30
Irgacare ® MP (Triclosan) 0.55
Sodium Saccharin 0.54
Cellulose Gum 0.80
Menthol 0.50
Sodium fluoride 0.44
Titanium Dioxide 0.30
Water Balance
The pH 7A and 7B respectively are approximately 2.7 and 9.2
EXAMPLE 8
A clinical trial was conducted to compare the dental product of Example 1 with an identical product that did not include monocalcium phosphate monohydrate. The commercial toothpastes Aim® and Colgate Total® were used as reference samples, the latter product being a formulation containing triclosan.
Protocol for the clinical was as follows. Panelists were carefully selected to meet a long list of criteria such as exhibiting visible tartar within only 1 to 2 months of a professional cleaning. Tartar present on the lingual aspect of the 6 anterior Mandibular teeth was evaluated according to the Volpe/Manhold Scoring Index. Following an initial tartar assessment, each panelist received a thorough dental cleaning. Panelists were then given Aim® toothpaste for use over the following 3 weeks to allow tartar to build. Another tartar evaluation identified the baseline for a panelist's normal tartar growth rate. A second dental prophylaxis was then performed to remove dental tartar rendering the panelists ready to receive the first test product (Example 1 with monocalcium phosphate monohydrate). Tartar evaluations were then conducted after 2 and 3 weeks of product usage. Aim® was then given to the panelists for a 4 week washout period.
The Mandibular Anterior teeth were then scaled to remove tartar buildup over the washout period. Panelists were next assigned to use Colgate Total® for the subsequent 3 weeks. Evaluations were again conducted after the 2 and 3 week usage period. In a further phase of the test, the panelists were directed to use Aim® for another 4 week washout. Again, the Mandibular Anterior teeth were scaled to remove tartar buildup over the 4 week washout period. Panelists were then assigned to Example 1 where monocalcium phosphate monohydrate was absent (replaced by 2% zinc citrate) for the next 3 weeks. Tartar evaluations were conducted at the 2 and 3 week interval. Results of the tests are reported in the Table below.
TABLE I
CALCULUS CLINICAL
% CALCULUS REDUCTION
AFTER 6 WEEKS
Aim ®  +5
Colgate Total ® −30
Example 1 (Calcium Phosphate) −42
Example 1 (Without Calcium −24
Phosphate)
Positive values indicate an increase in calculus. Negative values indicate a reduction. Table I reveals that Example 1 containing calcium phosphate had significantly better calculus inhibition performance than Aim®. The better performance is attributed to calcium phosphate which when absent from Example 1 allowed considerable more calculus formation.
EXAMPLE 9
A further study was conducted under a protocol similar to that described in Example 8 and utilizing some of the earlier data. All three cells of the test employed the same paste (sodium bicarbonate) composition as outlined below.
Paste Composition 9A
INGREDIENT WEIGHT %
Polyol II (70% Sorbitol) 33.30 
Syloid 63XX (Hydrated Silica) 30.00 
Sodium Bicarbonate 10.00 
Sylox 15X 2.00
Polyethylene Glycol 1450 (PEG 32) 5.00
Sodium Lauryl Sulphate 2.98
Alcohol 38B 2.84
Flavor 1.30
Cellulose Gum 0.80
Saccharin 0.54
Menthol 0.50
Sodium Fluoride 0.44
Titanium Dioxide 0.30
Water Balance
The gel compositions (containing monocalcium phosphate monohydrate) were different for each of the test cells. The formulations are reported in the Tables below.
Gel Composition 9B-9D
WEIGHT %
COMPOSITION 9B 9C 9D
Glycerin 40.00 39.00 39.00
Pluronic F-127 20.00 21.00 21.00
Hydrogen Peroxide (35% Active) 4.285 4.285 4.285
Monocalcium Phosphate Monohydrate — 1.07 —
Disodium Phosphate — 0.20 —
Methyl Salicylate 0.50 0.50 0.50
Calcium Chloride — — 0.92
Phosphoric Acid (95% Active) 0.15 0.70 0.25
Colorant 0.005 0.01 0.01
Water Balance Balance Balance
Table II provides the calculus reduction % results.
TABLE II
Calculus Reduction Results
TEST CALCIUM/PHOSPHATE % CALCULUS
FORMULATION (ppm) REDUCTION
9A-B   0.0/3877 −24
9A-C  810/8000 −44
9A-D 1250/1380 −40
The study reveals that calcium is essential for a reduction in calculus. Levels of 810 and 1250 ppm calcium in combination with phosphate were sufficient to provide significant calculus reduction.
The foregoing description and examples illustrate selected embodiments of the present invention. In light thereof variations and modifications will be suggested to one skilled in the art, all of which are within the spirit and purview of this invention.

Claims (19)

What is claimed is:
1. An anti-tartar dental product comprising:
(i) a container;
(ii) an oral composition stored within the container, the composition comprising:
(a) a first composition comprising from about 0.01 to about 30% by weight of a water-soluble calcium phosphate or monolithic combination of water soluble calcium and phosphate salts, the composition having a pH less than 7; and
(b) a second composition including from about 0.01 to about 30% by weight of an alkaline material and an anti-caries effective amount of a fluoride ion source, the second composition having a pH greater than 7.5 and stored separately from the first composition in a manner to avoid contact between the phosphate and the alkaline material.
2. The product according to claim 1 wherein the water-soluble phosphate salt is monocalcium hydrogen phosphate.
3. The product according to claim 1 wherein the alkaline material is selected from the group consisting of sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, calcium carbonate, calcium oxide and mixtures thereof.
4. The product according to claim 1 wherein the pH of the first composition ranges from 2.5 to 5.5.
5. The product according to claim 1 wherein the pH of the second composition ranges from 7.2 to 11.
6. The product according to claim 1 wherein the pH of the first composition results from inclusion of a compound selected from the group consisting of hydrogen peroxide, inorganic acids, C2-C20 carboxylic acids and mixtures thereof.
7. The product according to claim 1 wherein the monolithic combination of water soluble calcium salts are selected from the group consisting of calcium chloride, calcium sulphate and calcium acetate and the respective phosphate salts are selected from the group consisting of sodium phosphate, ammonium phosphate and sodium ammonium phosphate.
8. The product according to claim 1 further comprising from about 0.01 to about 20% by weight of triclosan.
9. The product according to claim 1 further comprising from about 0.01 to about 20% by weight of a zinc salt.
10. The product according to claim 1 further comprising from about 0.01 to about 5% by weight of a fluoride compound.
11. A method for controlling dental tartar comprising
(i) obtaining a product which comprises:
(a) a first composition comprising from about 0.01 to about 30% by weight of a water-soluble calcium phosphate or monolithic combination of water soluble calcium and phosphate salts, the composition having a pH less than 7; and
(b) a second composition comprising from about 0.01 to about 30% by weight of an alkaline material and an anti-caries effective amount of a fluoride ion source, the second composition having a pH greater than 7.5 and stored separately from the first composition in a manner to avoid contact between the phosphate and the alkaline material;
(ii) extruding a portion of first and second compositions onto a toothbrush; and
(iii) brushing the teeth with the combination of first and second compositions.
12. The method according to claim 11 wherein the water-soluble phosphate salt is monocalcium hydrogen phosphate.
13. The method according to claim 11 wherein the alkaline material is selected from the group consisting of sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, calcium carbonate, calcium oxide and mixtures thereof.
14. The method according to claim 10 wherein the pH of the first composition ranges from 2.5 to 5.5.
15. The method according to claim 10 wherein the pH of the second composition ranges from 7.2 to 11.
16. The method according to claim 11 wherein the pH of the first composition results from inclusion of a compound selected from the group consisting of hydrogen peroxide, inorganic adds, C2-C20 carboxylic acids and mixtures thereof.
17. The method according to claim 11 wherein the monolithic combination of water soluble calcium salts are selected from the group consisting of calcium chloride, calcium citrate, calcium sulphate and calcium acetate and the respective phosphate salts are selected from the group consisting of sodium phosphate, ammonium phosphate and sodium ammonium phosphate.
18. The method according to claim 11 further comprising from about 0.01 to about 20% by weight of triclosan.
19. The method according to claim 11 further comprising from about 0.01 to about 20% by weight of a zinc salt.
US09/538,564 1999-04-16 2000-03-29 Anti-tartar dental product and method Expired - Lifetime US6248310B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/538,564 US6248310B1 (en) 1999-04-16 2000-03-29 Anti-tartar dental product and method

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12977999P 1999-04-16 1999-04-16
US09/395,064 US6207139B1 (en) 1999-04-16 1999-09-13 Anti-tartar dental product and related method
US09/538,564 US6248310B1 (en) 1999-04-16 2000-03-29 Anti-tartar dental product and method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/395,064 Division US6207139B1 (en) 1999-04-16 1999-09-13 Anti-tartar dental product and related method

Publications (1)

Publication Number Publication Date
US6248310B1 true US6248310B1 (en) 2001-06-19

Family

ID=22441561

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/395,064 Expired - Lifetime US6207139B1 (en) 1999-04-16 1999-09-13 Anti-tartar dental product and related method
US09/538,564 Expired - Lifetime US6248310B1 (en) 1999-04-16 2000-03-29 Anti-tartar dental product and method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/395,064 Expired - Lifetime US6207139B1 (en) 1999-04-16 1999-09-13 Anti-tartar dental product and related method

Country Status (9)

Country Link
US (2) US6207139B1 (en)
EP (1) EP1178773B1 (en)
AT (1) ATE302588T1 (en)
AU (1) AU3432600A (en)
CA (1) CA2365363A1 (en)
DE (1) DE60022180T2 (en)
ES (1) ES2248056T3 (en)
MX (1) MXPA01010343A (en)
WO (1) WO2000062749A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555094B1 (en) * 1999-11-12 2003-04-29 The Procter & Gamble Company Stannous oral compositions
US20050084461A1 (en) * 2003-10-16 2005-04-21 Winston Anthony E. Tooth enamel rejuvenating toothpaste
US20060062814A1 (en) * 2002-11-22 2006-03-23 Stier Roger E Oral compositions which mask the salty taste of salts
US20060134020A1 (en) * 2004-12-21 2006-06-22 Robinson Richard S Anti-caries oral care composition with a chelating agent
US20060140882A1 (en) * 2004-12-29 2006-06-29 Tambs Gary E Two phase whitening oral care composition
US20060286044A1 (en) * 2004-12-21 2006-12-21 Robinson Richard S Anti-caries oral care composition with xylitol
US20070183984A1 (en) * 2006-02-03 2007-08-09 Wm. Wrigley Jr. Company Calcium phosphate salts in oral compositions suitable as a tooth remineralizing agent
US20080152602A1 (en) * 2006-12-22 2008-06-26 Douglas Andersen Anti-calculus dental composition and methods for using same
US20090092562A1 (en) * 2007-04-30 2009-04-09 Colgate-Palmolive Company Oral Care Composition To Reduce Or Eliminate Dental Sensitivity
US8758729B2 (en) 2009-05-18 2014-06-24 Colgate-Palmolive Company Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
US8911712B2 (en) 2010-10-04 2014-12-16 Church & Dwight, Co., Inc. Multi-purposed dentifrice
US9149661B2 (en) 2009-12-17 2015-10-06 Colgate-Palmolive Company Anti-erosion toothpaste composition
US10610707B2 (en) 2010-01-29 2020-04-07 Colgate-Palmolive Company Oral care product for sensitive enamel care
US10881492B2 (en) 2014-08-15 2021-01-05 The Procter & Gamble Company Oral care compositions and regimens

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2354636A (en) * 1999-09-25 2001-03-28 Ibm Mounting chips on substrates
US6669931B2 (en) * 2001-03-29 2003-12-30 Curozone Ireland Limited Formulation for the remineralization of teeth
EP1438952A4 (en) * 2001-10-25 2005-01-19 Kao Corp Tooth agent
US20050074526A1 (en) * 2002-02-11 2005-04-07 Edizone, Lc Method for a consumer to individually flavor his own dairy dessert
US20050100647A1 (en) * 2002-02-11 2005-05-12 Edizone, Lc Method for creating an intense flavor sensation by use of tongue dropsicles
US6953817B2 (en) 2002-08-05 2005-10-11 Colgate-Palmolive Company Dual component dentinal desensitizing dentifrice
CA2495565C (en) * 2002-08-05 2012-04-24 Colgate-Palmolive Company Dentinal desensitizing dentifrice
US8974772B2 (en) 2004-12-28 2015-03-10 Colgate-Palmolive Company Two phase toothpaste composition
US8026285B2 (en) * 2007-09-04 2011-09-27 Bezwada Biomedical, Llc Control release of biologically active compounds from multi-armed oligomers
US8048980B2 (en) 2007-09-17 2011-11-01 Bezwada Biomedical, Llc Hydrolysable linkers and cross-linkers for absorbable polymers
US8053591B2 (en) 2007-09-26 2011-11-08 Bezwada Biomedical, Llc Functionalized biodegradable triclosan monomers and oligomers for controlled release
EP2167627A1 (en) * 2008-02-21 2010-03-31 S.C.Johnson & Son, Inc Cleaning composition that provides residual benefits
US8980813B2 (en) 2008-02-21 2015-03-17 S. C. Johnson & Son, Inc. Cleaning composition having high self-adhesion on a vertical hard surface and providing residual benefits
US8143206B2 (en) * 2008-02-21 2012-03-27 S.C. Johnson & Son, Inc. Cleaning composition having high self-adhesion and providing residual benefits
BRPI0908179A2 (en) * 2008-02-21 2015-11-24 Johnson & Son Inc S C cleaning composition having high self-adhesion and providing residual benefits
US8993502B2 (en) 2008-02-21 2015-03-31 S. C. Johnson & Son, Inc. Cleaning composition having high self-adhesion to a vertical hard surface and providing residual benefits
US9481854B2 (en) 2008-02-21 2016-11-01 S. C. Johnson & Son, Inc. Cleaning composition that provides residual benefits
US9410111B2 (en) * 2008-02-21 2016-08-09 S.C. Johnson & Son, Inc. Cleaning composition that provides residual benefits
US8741268B2 (en) * 2009-09-10 2014-06-03 Preventive Technologies, Inc. Dental prophylactic paste
CN104519858B (en) * 2012-08-10 2018-04-20 高露洁-棕榄公司 Include the mouthwash of epoxide, the first acid and the second acid
DE102012214540A1 (en) 2012-08-15 2014-02-20 Helmholtz-Zentrum für Infektionsforschung GmbH Tooth filling materials and coatings for inhibiting the biofilm formation of Streptococcus mutans and their production
CA2930455A1 (en) * 2012-11-26 2014-05-30 Apollonia Health Inc. Compositions, uses and methods for treating or preventing dental caries
ES2734650T3 (en) 2014-07-10 2019-12-11 Procter & Gamble Oral anti-calculus compositions
AU2015301623B2 (en) * 2014-08-15 2018-10-18 The Procter & Gamble Company Oral care compositions with an enhanced sensory experience
EP3222326A1 (en) * 2016-03-23 2017-09-27 Unilever PLC Toothpaste composition
BR112019008013A2 (en) * 2016-10-20 2019-10-01 3M Innovative Properties Co Methods and Kits to Remove Calculus Using a Metal Ion and Baking
US20180318191A1 (en) * 2017-05-04 2018-11-08 Phoenix Dental, Inc. Dental Composition and Method
US11529295B2 (en) 2019-09-25 2022-12-20 Church & Dwight Co., Inc. Oral care composition

Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2164383A1 (en) 1971-02-12 1972-08-17 Bartheld, Frits van, Dr., Utrecht (Niederlande) Agents with the demineralization of tooth enamel inhibiting or the mineralization of tooth enamel promoting effect and process for the production of this agent
GB1408922A (en) 1972-02-02 1975-10-08 Blendax Werke Schneider Co Process and composition for the remineralisation and prevention of demineralisation of human teeth
US4080440A (en) 1974-12-13 1978-03-21 The Procter & Gamble Company Method for remineralizing tooth enamel
US4183915A (en) 1978-10-13 1980-01-15 Colgate-Palmolive Company Stable solution for dental remineralization
US4460565A (en) 1981-07-03 1984-07-17 Intradal N.V. Anticariogenic remineralizing dentifrice
US4885155A (en) 1982-06-22 1989-12-05 The Procter & Gamble Company Anticalculus compositions using pyrophosphate salt
US5037639A (en) 1989-05-24 1991-08-06 American Dental Association Health Foundation Methods and compositions for mineralizing calcified tissues
US5531983A (en) 1990-10-08 1996-07-02 Purac Biochem B.V. Oral hygiene preparation
US5534244A (en) 1989-05-24 1996-07-09 Tung; Ming S. Methods and compositions for mineralizing and/or fluoridating calcified tissues with amorphous strontium compounds
US5571502A (en) 1995-08-08 1996-11-05 Enamelon Research Stable single-part compositions and the use thereof for remineralization of lesions in teeth
US5599527A (en) 1994-11-14 1997-02-04 Colgate-Palmolive Company Dentifrice compositions having improved anticalculus properties
US5603922A (en) 1995-08-08 1997-02-18 Enamelon Inc. Processes and compositions for the remineralization of teeth
US5605675A (en) 1995-06-06 1997-02-25 Enamelon Inc. Processes and compositions for remineralization and prevention of demineralization of dental enamel
JPH09143043A (en) 1995-11-24 1997-06-03 Lion Corp Composition for softening and dissolving dental calculus
US5843406A (en) 1998-01-12 1998-12-01 Colgate Palmolive Company Dual components antiplaque dentifrice compositions
US5855871A (en) 1997-08-12 1999-01-05 Colgate-Palmolive Company Effervescent two component bicarbonate and acid containing dentifrice
US5858333A (en) 1998-08-07 1999-01-12 Enamelon, Inc. Two-part oral products and methods of using same to remineralize teeth
US5891448A (en) 1995-01-06 1999-04-06 American Dental Association Health Foundation Control of calcium fluoride formation in mouth rinses, dentifrices and gels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891211A (en) * 1988-06-29 1990-01-02 Church & Dwight Co., Inc. Stable hydrogen peroxide-releasing dentifice
US5135548A (en) * 1991-05-08 1992-08-04 Air Products And Chemicals, Inc. Oxygen selective desiccants
US5713738A (en) * 1995-12-12 1998-02-03 Britesmile, Inc. Method for whitening teeth
US5645428A (en) * 1995-12-12 1997-07-08 Britesmile, Inc. Method for whitening teeth

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2164383A1 (en) 1971-02-12 1972-08-17 Bartheld, Frits van, Dr., Utrecht (Niederlande) Agents with the demineralization of tooth enamel inhibiting or the mineralization of tooth enamel promoting effect and process for the production of this agent
GB1408922A (en) 1972-02-02 1975-10-08 Blendax Werke Schneider Co Process and composition for the remineralisation and prevention of demineralisation of human teeth
US4080440A (en) 1974-12-13 1978-03-21 The Procter & Gamble Company Method for remineralizing tooth enamel
US4183915A (en) 1978-10-13 1980-01-15 Colgate-Palmolive Company Stable solution for dental remineralization
US4460565A (en) 1981-07-03 1984-07-17 Intradal N.V. Anticariogenic remineralizing dentifrice
US4885155A (en) 1982-06-22 1989-12-05 The Procter & Gamble Company Anticalculus compositions using pyrophosphate salt
US5037639A (en) 1989-05-24 1991-08-06 American Dental Association Health Foundation Methods and compositions for mineralizing calcified tissues
US5268167A (en) 1989-05-24 1993-12-07 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5437857A (en) 1989-05-24 1995-08-01 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5534244A (en) 1989-05-24 1996-07-09 Tung; Ming S. Methods and compositions for mineralizing and/or fluoridating calcified tissues with amorphous strontium compounds
US5531983A (en) 1990-10-08 1996-07-02 Purac Biochem B.V. Oral hygiene preparation
US5599527A (en) 1994-11-14 1997-02-04 Colgate-Palmolive Company Dentifrice compositions having improved anticalculus properties
US5698182A (en) 1994-11-14 1997-12-16 Colgate Palmolive Company Dentifrice composition containing calcium peroxide having heightened tooth whitening effect
US5891448A (en) 1995-01-06 1999-04-06 American Dental Association Health Foundation Control of calcium fluoride formation in mouth rinses, dentifrices and gels
US5895641A (en) 1995-06-06 1999-04-20 Enamelon Processes and composition for remineralization and prevention of demineralization of dental enamel
US5605675A (en) 1995-06-06 1997-02-25 Enamelon Inc. Processes and compositions for remineralization and prevention of demineralization of dental enamel
US5833957A (en) 1995-08-08 1998-11-10 Enamelon, Inc. Processes and compositions for the remineralization of teeth
US5571502A (en) 1995-08-08 1996-11-05 Enamelon Research Stable single-part compositions and the use thereof for remineralization of lesions in teeth
US5866102A (en) 1995-08-08 1999-02-02 Enamelon, Inc. Stable single-part compositions and the use thereof for remineralization of lesions in teeth
US5614175A (en) 1995-08-08 1997-03-25 Enamelon Inc. Stable single-part compositions and the use thereof for remineralization of lesions in teeth
US5603922A (en) 1995-08-08 1997-02-18 Enamelon Inc. Processes and compositions for the remineralization of teeth
JPH09143043A (en) 1995-11-24 1997-06-03 Lion Corp Composition for softening and dissolving dental calculus
US5855871A (en) 1997-08-12 1999-01-05 Colgate-Palmolive Company Effervescent two component bicarbonate and acid containing dentifrice
US5843406A (en) 1998-01-12 1998-12-01 Colgate Palmolive Company Dual components antiplaque dentifrice compositions
US5858333A (en) 1998-08-07 1999-01-12 Enamelon, Inc. Two-part oral products and methods of using same to remineralize teeth

Non-Patent Citations (16)

* Cited by examiner, † Cited by third party
Title
Hall et al Caries Res 32:312, 1998.*
http://www.Enamelon.com/prof/pf/ss.htm Latest Clinical Data "Enamelon"(R) Abstracts From Enamelon Professional Website (Jul. 8, 1999).*
http://www.Enamelon.com/prof/pf/ss.htm Latest Clinical Data "Enamelon"® Abstracts From Enamelon Professional Website (Jul. 8, 1999).*
Karpos et al J. Dent. Res. 77 (Spec.155. A.):246, 1998.*
Kleber et al J. Dent. Res 77 (Spec 155 B) 843, 1998.*
Mundorf et al J. Dent. Res. 77 (Spec. 155 A):246, 1990.*
Munoz et al J. Dent. Res. 77 (Spec. 155 A):242, 1998.*
Rosenblum et al J. Dent. Res 76 (Spec. 155.):17, 1997.*
Schemeltorn et al J.Dent. Res 77(Spec. 155 A):188, 1998.*
Schemeltron et al J. Dent. Res 76 (Spec. 155):376, 1997.*
Snagne-Agnero et al J. Dent. Res. 76 (Spec 155):255, 1997.*
Soap/Cosmetics/Chemical Specialties "Beyond Fluoride, The Enamelon Phenomenon"-p. 66, Jun. 1998.
Tanzer et al Caries Res 31: 288, 1997.*
Tanzer et al J. Dent. Res. 76 (Spec. 155):134, 1997.*
Wolinsky et al J. Dent. Res. 77(Spec. 155. A): 246, 1998.*
Yaskell et al J. Dent. Res. 77 (Spec. 155 A):188, 1998.*

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555094B1 (en) * 1999-11-12 2003-04-29 The Procter & Gamble Company Stannous oral compositions
US20060062814A1 (en) * 2002-11-22 2006-03-23 Stier Roger E Oral compositions which mask the salty taste of salts
US20050084461A1 (en) * 2003-10-16 2005-04-21 Winston Anthony E. Tooth enamel rejuvenating toothpaste
US8858920B2 (en) 2004-12-21 2014-10-14 Colgate-Palmolive Company Anti-caries oral care composition with xylitol
US20060134020A1 (en) * 2004-12-21 2006-06-22 Robinson Richard S Anti-caries oral care composition with a chelating agent
US20060286044A1 (en) * 2004-12-21 2006-12-21 Robinson Richard S Anti-caries oral care composition with xylitol
US20060140882A1 (en) * 2004-12-29 2006-06-29 Tambs Gary E Two phase whitening oral care composition
US20070183984A1 (en) * 2006-02-03 2007-08-09 Wm. Wrigley Jr. Company Calcium phosphate salts in oral compositions suitable as a tooth remineralizing agent
US20080152602A1 (en) * 2006-12-22 2008-06-26 Douglas Andersen Anti-calculus dental composition and methods for using same
US8298516B2 (en) 2006-12-22 2012-10-30 Douglas Anderson Calculus dissolving dental composition and methods for using same
US20090092562A1 (en) * 2007-04-30 2009-04-09 Colgate-Palmolive Company Oral Care Composition To Reduce Or Eliminate Dental Sensitivity
US8758729B2 (en) 2009-05-18 2014-06-24 Colgate-Palmolive Company Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
US9149661B2 (en) 2009-12-17 2015-10-06 Colgate-Palmolive Company Anti-erosion toothpaste composition
US10610707B2 (en) 2010-01-29 2020-04-07 Colgate-Palmolive Company Oral care product for sensitive enamel care
US8911712B2 (en) 2010-10-04 2014-12-16 Church & Dwight, Co., Inc. Multi-purposed dentifrice
US10881492B2 (en) 2014-08-15 2021-01-05 The Procter & Gamble Company Oral care compositions and regimens

Also Published As

Publication number Publication date
DE60022180D1 (en) 2005-09-29
US6207139B1 (en) 2001-03-27
WO2000062749A1 (en) 2000-10-26
DE60022180T2 (en) 2006-03-23
MXPA01010343A (en) 2002-03-27
ES2248056T3 (en) 2006-03-16
EP1178773B1 (en) 2005-08-24
AU3432600A (en) 2000-11-02
ATE302588T1 (en) 2005-09-15
CA2365363A1 (en) 2000-10-26
EP1178773A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
US6248310B1 (en) Anti-tartar dental product and method
US6214321B1 (en) Remineralization of teeth
US5554358A (en) Dental compositions with zinc and bicarbonate salts
US5632972A (en) Method for treating gingival and periodontal tissues
US5597554A (en) Oral hygiene system
EP0579729B1 (en) Quaternary ammonium antibacterial dentifrices with selected calcium abrasives
EP0548246B1 (en) Antimicrobial toothpaste
IE59557B1 (en) Anticalculus oral composition
EP0329069A1 (en) Anticalculus oral composition
US4309410A (en) Non-staining antigingivitis composition
JPH02286613A (en) New composition
US4590064A (en) Anticalculus oral composition
US4880619A (en) Anticalculus oral composition
US6692725B2 (en) Composition for oral care
MXPA00008245A (en) Remineralization of teeth
HK1004526B (en) Antimicorbial toothpaste
MXPA97004193A (en) Oral compositions containing statistical compounds stabilizes
HK1012244B (en) Quaternary ammonium antibacterial dentifrices with selected calcium abrasives

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12